Lv3
378 积分 2025-11-21 加入
Phellinus igniarius polysaccharides induced mitochondrial apoptosis of hepatic carcinoma by enhancing reactive oxygen species-mediated AKT/p53 signalling pathways
50分钟前
待确认
Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation
1天前
已完结
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
1天前
已完结
Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M-Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report
1天前
已完结
Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small‐cell Lung Cancer (NSCLC)
2天前
已完结
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2天前
已完结
Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals
6天前
已完结
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
6天前
已完结
Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies
6天前
已完结
Regression-Associated Macrophages Recruit Natural Killer Cells That Constrain Targeted Therapy Resistance
6天前
已完结
皖公网安备34019202002308
